Intra Cellular Therapies | 資産

Assets 変化する 日付
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
ALKERMES USD 2.12B 12.33M 2024-03
Biogen USD 26.57B 277.2M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Cytokinetics USD 808.08M 16.23M 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
Halozyme Therapeutics USD 1.84B 108.26M 2024-03
Intra Cellular Therapies USD 747.04M 18.74M 2024-03
J&J USD 171.97B 5.9B 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Novartis USD 94.33B 5.61B 2024-03
Prothena USD 623.19M 73.19M 2024-03
RedHill Biopharma USD 35.04M 23.8M 2023-06
Supernus Pharmaceuticals USD 1.3B 26.42M 2024-03
United Therapeutics USD 6.5B 671.8M 2024-03



Intra Cellular Therapies 資産 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jun 2024.